• Two world renowned research universities and regional partners will join forces with $8M grant from the California Institute for Regenerative Medicine (CIRM) to create UCLA and UC Irvine Alpha Stem Cell Clinic Consortium
  • Under the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and UCI Bill & Sue Gross Stem Cell Research Center, grant establishes first-of-its-kind cross-institutional “center of excellence” Alpha Stem Cell Clinic to conduct stem cell clinical trials
  • UCLA/UCI Alpha Stem Cell Clinic will attract diverse patient base in Los Angeles and Orange counties that together constitute about 34 percent of the total California population and 12 percent of the total U.S. population

In a first-of-its-kind collaboration, the University of California, Los Angeles, Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and University of California, Irvine Sue & Bill Gross Stem Cell Research Center received a five year $8M grant from the California Institute of Regenerative Medicine (CIRM), the state’s stem cell agency, to establish a CIRM Alpha Stem Cell Clinic “center of excellence” to conduct clinical trials for investigational stem cell therapies and provide critical resources and expertise in clinical research.

The $8M grant was one of three awarded today by CIRM as part of the CIRM Alpha Stem Cell Clinics (CASC) Network Initiative. The joint UCLA/UCI award under the direction of Dr. John Adams, a member of the UCLA Broad Stem Cell Research Center and professor in the department of orthopaedic surgery, will accelerate the implementation of clinical trials and delivery of stem cell therapies by providing world-class, state-of-the-art infrastructure to support clinical research.

Media Contact: 

Mirabai Vogt-James
(310) 983-1163
mvogt@mednet.ucla.edu